Remain compliant and safeguard your patients

As a Pharmacovigilance Service Provider focused on Biopharmaceuticals we will meet all your clinical trial and post-authorisation needs



 Request a Consultation

The three steps to compliance:

icon_Submit RFI_v2

Submit an RFI >

  • Secure a meeting with our experts
  • Put in place a CDA/NDA
  • Specify your needs and requests 
  • Our specialist will guide you to a tailored outsourcing solution

Part of your team >

  • Kick-off meeting and selection of the preferred approach
  • QVigilance resources assigned to your team to meet your regulatory needs
  • Excellent customer care




Submit an RFI


Compliance Achieved!

  • All your regulatory and business requirements are meet
  • Your PV system is in perfect compliance with EMA and FDA's regulations
  • You acquired a trusted partner, and we stay at your disposal for any future needs


Global Pharmacovigilance Service Provider




Compliant Safety Systems

QVigilance can set up and host your global safety database on our 21 CFR Part 11 / Eudralex Annex 11 and native E2B(R3) validated AB Cube SafetyEasy system which is compliant with the latest reporting requirements. We also provide our iQ customer portal where documents can be easily accessed and managed.

Clients Testimonials

"The team has always provided a very positive experience and professional service."
Bruno Maranda, MD, M.Sc.
President and Medical Director at MendeliKABS
"Quanticate has provided PV services for us for nearly a year now.  I have found them incredibly professional and supportive.  They have deep expertise which they match with a strong customer focus and responsiveness that make them ideal partners"
Chief Operation Officer

Request a consultation and speak with our PV experts!


Submit an RFI


Explore our latest blog posts


New PV practice guidance on ...

28 Apr, 2022

European Medicines Agency releases new draft good pharmacovigilance practice guidance on pregnancy prevention programmes and other pregnancy-specific risk minimisation measures. The European Medicines Agency (EMA) has ...

Read More

Updated guidance on QPPV and PSMF ...

10 Sep, 2020

The United Kingdom (UK) formally left the European Union (EU) on 31 January 2020, since then, there has been a transitionary arrangement in place maintaining the status quo regarding EU regulations on goods and services ...

Read More

UK Government publishes updated ...

10 Sep, 2020

The United Kingdom (UK) formally left the European Union (EU) on 31 January 2020 and since that time has been in a transition ‘phase’, during which time the UK and EU have been operating under EU regulations ‘acquis ...

Read More